SFT2D3 anticorps (N-Term)
-
- Antigène Voir toutes SFT2D3 Anticorps
- SFT2D3 (SFT2 Domain Containing 3 (SFT2D3))
-
Épitope
- N-Term
-
Reactivité
- Humain
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp SFT2D3 est non-conjugé
-
Application
- Western Blotting (WB)
- Purification
- Purified
- Immunogène
- SFT2 D3 antibody was raised in rabbit using the N terminal of SFT2 3 as the immunogen
- Top Product
- Discover our top product SFT2D3 Anticorps primaire
-
-
- Indications d'application
-
WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator. - Commentaires
-
SFT2D3 Blocking Peptide, catalog no. 33R-2823, is also available for use as a blocking control in assays to test for specificity of this SFT2D3 antibody
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Concentration
- Lot specific
- Buffer
- Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
- Conseil sur la manipulation
- Avoid repeated freeze/thaw cycles.
- Stock
- 4 °C/-20 °C
- Stockage commentaire
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
- Antigène
- SFT2D3 (SFT2 Domain Containing 3 (SFT2D3))
- Autre désignation
- SFT2D3 (SFT2D3 Produits)
- Synonymes
- anticorps 2610206C24Rik, anticorps AI847965, anticorps AW046173, anticorps SFT2 domain containing 3, anticorps SFT2D3, anticorps Sft2d3
- Sujet
- SFT2D3 may be involved in fusion of retrograde transport vesicles derived from an endocytic compartment with the Golgi complex. Synonyms: Polyclonal SFT2D3 antibody, Anti-SFT2D3 antibody, SFT2 domain containing 3 antibody, MGC5391 antibody.
-